Market Overview:
The global purified human proteins market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for purified human proteins from laboratories and medical applications. The North American region is expected to dominate the global purified human proteins market during the forecast period, followed by Europe and Asia Pacific.
Product Definition:
Purified human proteins are proteins that have been purified from human cells. They are important for a variety of purposes, including research, drug development, and diagnostics.
Native Purified Human Proteins:
The global native purified human proteins market size was valued at USD 8.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period on account of rising demand for animal-free food products across the globe. The growing awareness among consumers regarding health, fitness & nutrition is anticipated to drive growth over the next seven years.
Recombinant Purified Human Proteins:
Recombinant purified human proteins are the proteins that are produced by the genetic engineering technology. The recombinant purified human proteins have a wide range of applications such as pharmaceuticals, biotechnology, research & development and food industry. Recombinant Purified Human Proteins (r-Protein) is used in various end-use industries such as pharmaceuticals, biotechnology research & development and food industry.
Application Insights:
Laboratories application segment led the global market in 2017 and is projected to continue its dominance over the forecast period. This is owing to a large number of research projects that use human proteins as tools for studying various biological processes. Moreover, increasing R&D investments by companies for developing new products based on purified human proteins will boost growth over the coming years.
Medical application segment is expected to grow at a significant rate during the forecast period due to rising incidences of chronic diseases such as cancer, cardiovascular diseases and diabetes among others which are associated with unhealthy lifestyles including lack of physical exercise and improper dietary habits. Thus rising demand for healthy lifestyle practices coupled with growing health consciousness among individuals will drive medical applications over the next seven years.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance over the forecast period owing to increasing R&D activities and high healthcare expenditure. In addition, rising incidence of chronic diseases such as cancer, diabetes, & cardiovascular disorders are anticipated to boost product demand in laboratories and medical applications.
Asia Pacific is estimated to be the fastest-growing regional market from 2018 to 2030 due primarily on improving healthcare infrastructure coupled with growing awareness about advanced therapies among end users.
Growth Factors:
- Increasing demand for purified human proteins in the research and development of new drugs and therapies
- Growing prevalence of chronic diseases that require regular protein therapy
- Rising number of clinical trials being conducted to test the efficacy of novel protein-based therapies
- Proliferation of monoclonal antibody (mAb) production facilities worldwide
- Technological advancements in purification methods that improve the yield and quality of purified human proteins
Scope Of The Report
Report Attributes
Report Details
Report Title
Purified Human Proteins Market Research Report
By Type
Native Purified Human Proteins, Recombinant Purified Human Proteins
By Application
Laboratories, Medical
By Companies
Merck, OriGene, Abcam, Aalto Bio Reagents, Santa Cruz Biotechnology, Rockland, Cusabio, RayBiotech, Enzyme Research Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Purified Human Proteins Market Report Segments:
The global Purified Human Proteins market is segmented on the basis of:
Types
Native Purified Human Proteins, Recombinant Purified Human Proteins
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratories, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- OriGene
- Abcam
- Aalto Bio Reagents
- Santa Cruz Biotechnology
- Rockland
- Cusabio
- RayBiotech
- Enzyme Research Laboratories
Highlights of The Purified Human Proteins Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Native Purified Human Proteins
- Recombinant Purified Human Proteins
- By Application:
- Laboratories
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Purified Human Proteins Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Purified human proteins are proteins that have been removed from the body or tissues where they were produced. This can be done by a variety of methods, including precipitation with alcohol, ultrafiltration, and chromatography.
Some of the key players operating in the purified human proteins market are Merck, OriGene, Abcam, Aalto Bio Reagents, Santa Cruz Biotechnology, Rockland, Cusabio, RayBiotech, Enzyme Research Laboratories.
The purified human proteins market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Purified Human Proteins Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Purified Human Proteins Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Purified Human Proteins Market - Supply Chain
4.5. Global Purified Human Proteins Market Forecast
4.5.1. Purified Human Proteins Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Purified Human Proteins Market Size (000 Units) and Y-o-Y Growth
4.5.3. Purified Human Proteins Market Absolute $ Opportunity
5. Global Purified Human Proteins Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Purified Human Proteins Market Size and Volume Forecast by Type
5.3.1. Native Purified Human Proteins
5.3.2. Recombinant Purified Human Proteins
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Purified Human Proteins Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Purified Human Proteins Market Size and Volume Forecast by Application
6.3.1. Laboratories
6.3.2. Medical
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Purified Human Proteins Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Purified Human Proteins Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Purified Human Proteins Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Purified Human Proteins Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Purified Human Proteins Demand Share Forecast, 2019-2026
9. North America Purified Human Proteins Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Purified Human Proteins Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Purified Human Proteins Market Size and Volume Forecast by Application
9.4.1. Laboratories
9.4.2. Medical
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Purified Human Proteins Market Size and Volume Forecast by Type
9.7.1. Native Purified Human Proteins
9.7.2. Recombinant Purified Human Proteins
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Purified Human Proteins Demand Share Forecast, 2019-2026
10. Latin America Purified Human Proteins Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Purified Human Proteins Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Purified Human Proteins Market Size and Volume Forecast by Application
10.4.1. Laboratories
10.4.2. Medical
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Purified Human Proteins Market Size and Volume Forecast by Type
10.7.1. Native Purified Human Proteins
10.7.2. Recombinant Purified Human Proteins
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Purified Human Proteins Demand Share Forecast, 2019-2026
11. Europe Purified Human Proteins Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Purified Human Proteins Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Purified Human Proteins Market Size and Volume Forecast by Application
11.4.1. Laboratories
11.4.2. Medical
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Purified Human Proteins Market Size and Volume Forecast by Type
11.7.1. Native Purified Human Proteins
11.7.2. Recombinant Purified Human Proteins
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Purified Human Proteins Demand Share, 2019-2026
12. Asia Pacific Purified Human Proteins Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Purified Human Proteins Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Purified Human Proteins Market Size and Volume Forecast by Application
12.4.1. Laboratories
12.4.2. Medical
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Purified Human Proteins Market Size and Volume Forecast by Type
12.7.1. Native Purified Human Proteins
12.7.2. Recombinant Purified Human Proteins
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Purified Human Proteins Demand Share, 2019-2026
13. Middle East & Africa Purified Human Proteins Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Purified Human Proteins Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Purified Human Proteins Market Size and Volume Forecast by Application
13.4.1. Laboratories
13.4.2. Medical
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Purified Human Proteins Market Size and Volume Forecast by Type
13.7.1. Native Purified Human Proteins
13.7.2. Recombinant Purified Human Proteins
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Purified Human Proteins Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Purified Human Proteins Market: Market Share Analysis
14.2. Purified Human Proteins Distributors and Customers
14.3. Purified Human Proteins Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. OriGene
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abcam
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Aalto Bio Reagents
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Santa Cruz Biotechnology
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Rockland
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cusabio
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. RayBiotech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Enzyme Research Laboratories
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
